Author Question: Which of the following does the single-group, posttest-only design control for? A) maturation B) ... (Read 32 times)

mckennatimberlake

  • Hero Member
  • *****
  • Posts: 559
Which of the following does the single-group, posttest-only design control for?
 
  A) maturation
  B) placebo effects
  C) history
  D) None of the above

Question 2

The single-group, posttest-only design
 
  A) cannot be used in human research.
  B) is one of the strongest designs possible.
  C) is weak because there is no manipulation of a variable.
  D) includes a manipulation of an independent variable.



Jossy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Answer: D

Answer to Question 2

Answer: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library